NSMD MEDICAL LTD

Company Registration Number:
15461313 (England and Wales)

Unaudited statutory accounts for the year ended 28 February 2025

Period of accounts

Start date: 02 February 2024

End date: 28 February 2025

NSMD MEDICAL LTD

Contents of the Financial Statements

for the Period Ended 28 February 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

NSMD MEDICAL LTD

Company Information

for the Period Ended 28 February 2025




Director: Nicholas Dixon
Registered office: 73
Dollis Park
London
London
GBR
N3 1HJ
Company Registration Number: 15461313 (England and Wales)

NSMD MEDICAL LTD

Directors' Report Period Ended 28 February 2025

The directors present their report with the financial statements of the company for the period ended 28 February 2025

Principal Activities

Private Medical Doctor Medical Consultancy work

Political and charitable donations

n/a

Company policy on the employment of disabled persons

n/a

Directors

The director(s) shown below were appointed to the company during the period
Nicholas Dixon
02 February 2024

This report was approved by the board of directors on 29 October 2025
And Signed On Behalf Of The Board By:

Name: Nicholas Dixon
Status: Director

NSMD MEDICAL LTD

Profit and Loss Account

for the Period Ended 28 February 2025


Notes
13 months to
28 Feb 2025
£
Turnover 1,140
Cost of sales ( 0 )
Gross Profit or (Loss) 1,140
Income from coronavirus (COVID-19) business support grants 0
Administrative Expenses ( 96 )
Operating Profit or (Loss) 1,044
Profit or (Loss) Before Tax 1,044
Tax on Profit ( 805 )
Profit or (Loss) for Period 239

The notes form part of these financial statements

NSMD MEDICAL LTD

Balance sheet

As at 28 February 2025


Notes
13 months to
28 Feb 2025
£
Fixed assets
Total fixed assets: -
Current assets
Cash at bank and in hand: 239
Total current assets: 239
Net current assets (liabilities): 239
Total assets less current liabilities: 239
Creditors: amounts falling due after more than one year: 4 ( 0 )
Accruals and deferred income: ( 0 )
Total net assets (liabilities): 239

The notes form part of these financial statements

NSMD MEDICAL LTD

Balance sheet continued

As at 28 February 2025


Notes
13 months to
28 Feb 2025
£
Capital and reserves
Called up share capital: 1
Revaluation reserve: 5 238
Profit and loss account: 0
Shareholders funds: 239

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 29 October 2025
And Signed On Behalf Of The Board By:

Name: Nicholas Dixon
Status: Director

The notes form part of these financial statements

NSMD MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    Self assessed as minimal activity in business during this time period

NSMD MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 2. Employees

    13 months to
    28 Feb 2025
    Average number of employees during the period 0

NSMD MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

  • 3. Off balance sheet disclosure

    No

NSMD MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

4.Creditors: amounts falling due after more than one year

13 months to
28 Feb 2025
£
Bank loans and overdrafts 0
Amounts due under finance leases and hire purchase contracts 0
Other creditors 0
Total 0

n/a

NSMD MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 28 February 2025

5. Revaluation reserve

13 months to
28 Feb 2025
£
Surplus or deficit after revaluation 238
Balance at 28 February 2025 238

no revaluation perfomed